The Safety, Pharmacokinetics, and Pharmacodynamics of TD-8236, an Inhaled pan-JAK Inhibitor: Results from Part C of a First-in-Human Study in Participants with Moderate to Severe Asthma-MedSci.cn

The Safety, Pharmacokinetics, and Pharmacodynamics of TD-8236, an Inhaled pan-JAK Inhibitor: Results from Part C of a First-in-Human Study in Participants with Moderate to Severe Asthma

Pfeifer, ND; Nguyen, T; Lombardi, DA; Colley, K; Yates, W; Kaufman, E; Graham, RA; Bourdet, DL; Leaker, B; Singh, D

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022; 205 ():

科室
- - 订阅+
  - 更多科室
工具
服务